|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit (loss) | |||||
| Operating expenses: | |||||
| Research and development expenses (including amounts for related party of $947,084 and $1,418,887 for the years ended December 31, 2025 and 2024, respectively) | |||||
| Selling, general and administrative expenses | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Issuance cost of senior secured convertible note measured at fair value | |||||
| Fair value change of senior secured convertible note | |||||
| Other income, net | |||||
| Non-operating income (expenses), net | |||||
| Interest expense | |||||
| Issuance cost of senior secured convertible note measured at fair value | |||||
| Fair value change of senior secured convertible note | |||||
| Other income, net | |||||
| Other income (expenses), net | |||||
| Total non-operating expenses, net | |||||
| Net loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per common share - basic and diluted | |||||
| Weighted-average shares used in computing net loss per common share-basic and diluted | |||||
| Net loss per common share - basic | |||||
| Net loss per common share - diluted | |||||
| Weighted-average shares used in computing net loss per common share-basic | |||||
| Weighted-average shares used in computing net loss per common share-diluted | |||||
Loading...